NEO

Q: What is the price of NeoGenomics (NEO) today?

The price of NeoGenomics (NEO) today is $ 8.96, with return of -11.29% compared to the last year. The price of NeoGenomics (NEO) started the year trading around $ 11.76 and today it is at $ 8.96. Follow the real-time price chart, the historical price of NeoGenomics (NEO) and international markets.

Q: When does NeoGenomics (NEO) pay dividends?

NeoGenomics (NEO) did not distribute dividends in the last year.

Q: Is NeoGenomics (NEO) worth it?

Currently, NeoGenomics (NEO) is priced at $ 8.96, with a P/E of -11.74%, representing a deviation of -1,762% from its historical average P/E. In the last year, the stock showed a variation of -11.29 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -11.29%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy NeoGenomics (NEO) stock?

Investing in stocks of NeoGenomics (NEO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of NeoGenomics (NEO) yield today?

The yield of NeoGenomics (NEO) was -20.50% in the last month, -11.29% in the last year and -80.04% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of NeoGenomics (NEO) today, the total investment would be $ 896.00, based on the current price of $ 8.96.If past performance were to repeat, the return on your investment would be:In 1 year: $ 794.84In 5 years: $ 178.84In 10 years: $ 1,179.05It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NeoGenomics Inc.

Price

$ 8.96

return (12m)

-11.29%

p/e

-11.74

p/b

1.52

DIVIDEND YIELD

0.00%

price NEO

NEO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NEO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-20.50%

3 months

-24.71%

1 year

-11.29%

2 years

-43.86%

5 years

-80.04%

10 years

31.59%

Fundamentals NEO

review the fundamentals of NeoGenomics shares

P/E

-11.74

Sector: -10.42 Industry: -4.97

P/S (Price-to-Sales)

1.74

Sector: -0.12 Industry: -2.02

P/B

1.52

Sector: 1.81 Industry: 1.92

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-7.94%

Sector: -48.25% Industry: -43.25%

ROE

-12.91%

Sector: -65.66% Industry: -71.97%

ROIC

-3.49%

Sector: -421.51% Industry: -79.39%

NET MARGIN

-14.85%

Sector: -40.80% Industry: -43.96%

GROSS MARGIN

43.21%

Sector: 37.55% Industry: 43.09%

OPERATING MARGIN

-12.12%

Sector: -36.78% Industry: -40.92%

EV/EBITDA

-32.78

Sector: -8.80 Industry: -5.22

EV/EBIT

-11.90

Sector: -11.18 Industry: -8.63

PRICE-TO-ASSETS

0.93

Sector: 0.98 Industry: 1.00

BVPS

6.48

Sector: 2.24 Industry: 3.16

EPS

-0.84

Sector: -1.65 Industry: -1.60

EQUITY-TO-ASSETS RATIO

0.62

Sector: 0.31 Industry: 0.34

LIABILITIES / ASSETS

0.38

Sector: 0.39 Industry: 0.44

CAGR REVENUE 5 YEARS

8.47%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

66.87%

Sector: - Industry: -

Fundamentals NEO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	45.62	39.48	86.53%	0.57%	$ 941.53 B	31.66%
ISRG	62.59	9.96	15.92%	0.00%	$ 178.75 B	28.38%
TMO	29.23	3.66	12.52%	0.33%	$ 195.94 B	15.05%
SNY	13.02	1.41	10.86%	4.55%	$ 118.78 B	18.68%
NVS	22.66	6.81	30.04%	2.34%	$ 316.95 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	27.16	2.55	9.38%	2.90%	$ 125.30 B	13.00%
CVS	57.39	1.35	2.35%	3.33%	$ 101.47 B	0.44%
GSK	15.59	5.57	35.71%	2.82%	$ 118.88 B	17.48%
BSX	36.51	0.00	0.00%	0.00%	$ 105.81 B	14.44%
HCA	17.80	-43.58	-244.82%	0.54%	$ 120.77 B	8.97%
IDXX	49.59	32.73	65.99%	0.00%	$ 52.54 B	24.62%
RMD	25.12	5.91	23.51%	0.88%	$ 37.33 B	27.53%
DHR	41.21	2.83	6.88%	0.61%	$ 148.92 B	14.71%
INMD	9.23	1.27	13.73%	0.00%	$ 866.25 M	25.32%
PHG	29.32	2.36	8.06%	2.77%	$ 30.42 B	5.07%
FMS	11.89	0.80	6.75%	3.35%	$ 13.42 B	5.02%
SYK	45.72	6.62	14.48%	0.88%	$ 148.40 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NEO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	12/18/2020	12/30/2020	0,40000000

ABOUT THE COMPANY NeoGenomics

NeoGenomics Inc.

Average user rating I10

4.0 (1 people)

United States

28 years

Founded: 1998

1996

Time since IPO - 30 years

1.700

Employees

The Company NeoGenomics Inc. (United States), is listed on Nasdaq with a market value of $ 1.27 Billion, having an equity of $ 836.56 Millions.

With a total of 1.700 employees, the company is listed in the sector of Health and categorized in industry of Health Establishments.

In the last 12 months the Company had a revenue of $ 727.33 Millions, which generated a loss in the amount of $ -108.02 Millions.

As for its main indicators, the Company has a P/E ratio of -11.74, a P/BV ratio of 1.52 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker NEO.

Market cap

$ 1.27 Billion

Net worth

$ 836.56 Millions

US$ 836,560,000.00

Assets

$ 1.36 Billion

US$ 1,359,830,000.00

Total Shares Outstanding

129.00 Millions

129,000,000

Average Daily Trading Volume

$ 1.92 Million

US$ 1,920,018.00

Sector

Health

Industry

Health Establishments

NEO

NEO revenue and profits

Financial Results NEO

DRAG THE FRAME TO SEE MORE DATA

NEO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 77.92 21,95% (12M)

P/E

57.39

3.33%

ROE

2.35%

P/B

1.35

CI - Cigna

$ 271.63 --13,18% (12M)

P/E

11.22

2.08%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 43.65 --27,29% (12M)

P/E

-3.31

0.00%

ROE

-33.28%

P/B

1.10

HCA - HCA Healthcare

$ 532.81 62,85% (12M)

P/E

17.80

0.54%

ROE

-244.82%

P/B

-43.58

LLY - Eli Lilly

$ 990.33 20,22% (12M)

P/E

45.62

0.57%

ROE

86.53%

P/B

39.48

NVS - Novartis

$ 160.12 46,23% (12M)

P/E

22.66

2.34%

ROE

30.04%

P/B

6.81

TMO - Thermo Fisher Scientific

$ 501.97 --5,17% (12M)

P/E

29.23

0.33%

ROE

12.52%

P/B

3.66

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 77.92 21,95% (12 M)

P/L

57.39

3.33%

ROE

2.35%

P/VP

1.35

CI - Cigna

$ 271.63 --13,18% (12 M)

P/L

11.22

2.08%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 43.65 --27,29% (12 M)

P/L

-3.31

0.00%

ROE

-33.28%

P/VP

1.10

HCA - HCA Healthcare

$ 532.81 62,85% (12 M)

P/L

17.80

0.54%

ROE

-244.82%

P/VP

-43.58

LLY - Eli Lilly

$ 990.33 20,22% (12 M)

P/L

45.62

0.57%

ROE

86.53%

P/VP

39.48

NVS - Novartis

$ 160.12 46,23% (12 M)

P/L

22.66

2.34%

ROE

30.04%

P/VP

6.81

TMO - Thermo Fisher Scientific

$ 501.97 --5,17% (12 M)

P/L

29.23

0.33%

ROE

12.52%

P/VP

3.66

Frequently Asked Questions

What is the price of NeoGenomics (NEO) today?

The price of NeoGenomics (NEO) today is $ 8.96, with return of -11.29% compared to the last year. The price of NeoGenomics (NEO) started the year trading around $ 11.76 and today it is at $ 8.96. Follow the real-time price chart, the historical price of NeoGenomics (NEO) and international markets.

When does NeoGenomics (NEO) pay dividends?

NeoGenomics (NEO) did not distribute dividends in the last year.

Is NeoGenomics (NEO) worth it?

Currently, NeoGenomics (NEO) is priced at $ 8.96, with a P/E of -11.74%, representing a deviation of -1,762% from its historical average P/E. In the last year, the stock showed a variation of -11.29 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -11.29%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy NeoGenomics (NEO) stock?

Investing in stocks of NeoGenomics (NEO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of NeoGenomics (NEO) yield today?

The yield of NeoGenomics (NEO) was -20.50% in the last month, -11.29% in the last year and -80.04% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of NeoGenomics (NEO) today, the total investment would be $ 896.00, based on the current price of $ 8.96.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 794.84
In 5 years: $ 178.84
In 10 years: $ 1,179.05

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NEO

NeoGenomics Inc.

Price

return (12m)

p/e

p/b

DIVIDEND YIELD

Return on Investment NEO

review the fundamentals of NeoGenomics shares

P/E

P/S (Price-to-Sales)

P/B

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY NeoGenomics

NeoGenomics Inc.

United States

28 years

1996

1.700

PROFIT X PRICE NEO

Financial Results NEO

NEO cash flow

asset growth - NEO

NEO balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

TMO - Thermo Fisher Scientific

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

TMO - Thermo Fisher Scientific

Frequently Asked Questions